BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 7628144)

  • 1. Graves' disease and concurrent thyroid carcinoma. The importance of thyroid scintigraphy in Graves' disease.
    Joseph UA; Jhingran SG
    Clin Nucl Med; 1995 May; 20(5):416-8. PubMed ID: 7628144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic papillary carcinoma of the thyroid in a patient previously treated for Graves' disease.
    Yunusa GH; Kotze T; Brink A
    Ann Afr Med; 2014; 13(2):91-4. PubMed ID: 24705115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An unusual initial manifestation of metastatic papillary thyroid carcinoma: radioiodine uptake in lymph node metastatic lesions in a patient with Graves' disease.
    Newman SL; Griffith AY; Herbst AB; Yeh IT; Kukora JS
    Endocr Pract; 2002; 8(4):304-6. PubMed ID: 12173918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Graves' disease and papillary thyroid cancer--coincidence or association?].
    Kinkel B; Bucerius J; Risse JH
    Dtsch Med Wochenschr; 2007 May; 132(18):983-6. PubMed ID: 17457781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An autonomously functioning thyroid carcinoma associated with euthyroid Graves' disease.
    Michigishi T; Mizukami Y; Shuke N; Satake R; Noguchi M; Aburano T; Tonami N; Hisada K
    J Nucl Med; 1992 Nov; 33(11):2024-6. PubMed ID: 1432166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasonographic screening for detection of thyroid cancer in patients with Graves' disease.
    Kim WB; Han SM; Kim TY; Nam-Goong IS; Gong G; Lee HK; Hong SJ; Shong YK
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):719-25. PubMed ID: 15163336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyrotoxicosis due to metastatic papillary thyroid cancer in a patient with Graves' disease.
    Basaria S; Salvatori R
    J Endocrinol Invest; 2002; 25(7):639-42. PubMed ID: 12150341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does Graves' disease or thyrotoxicosis affect the prognosis of thyroid cancer.
    Hales IB; McElduff A; Crummer P; Clifton-Bligh P; Delbridge L; Hoschl R; Poole A; Reeve TS; Wilmshurst E; Wiseman J
    J Clin Endocrinol Metab; 1992 Sep; 75(3):886-9. PubMed ID: 1517381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Euthyroid Graves' orbitopathy and incidental papillary thyroid microcarcinoma.
    Melcescu E; Horton WB; Pitman KT; Vijayakumar V; Koch CA
    Hormones (Athens); 2013; 12(2):298-304. PubMed ID: 23933699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual vignette: Grave's disease.
    Onobrakpeya FA; Azizi G; Rosenberg R; Bower B
    Endocr Pract; 2000; 6(6):485. PubMed ID: 11202596
    [No Abstract]   [Full Text] [Related]  

  • 11. [Thyroid tuberculosis associated with papillary microcarcinoma of the thyroid gland: a case report].
    el Kohen A; Essakalli L; Amarti A; Benchekroun L; Jazouli N; Kzadri M
    Rev Laryngol Otol Rhinol (Bord); 2001; 122(3):205-8. PubMed ID: 11799865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aggressive behavior of papillary microcarcinoma in a patient with Graves' disease initially presenting as cystic neck mass.
    Braga M; Graf H; Ogata A; Batista J; Hakim NC
    J Endocrinol Invest; 2002 Mar; 25(3):250-3. PubMed ID: 11936468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early visualization of 99mTc-pertechnetate in metastatic thyroid cancer in a patient with Graves' disease.
    Carr HA; Temple TE; Staab EV
    J Nucl Med; 1971 Jan; 12(1):40-2. PubMed ID: 5107457
    [No Abstract]   [Full Text] [Related]  

  • 14. Toxic adenoma and papillary thyroid carcinoma in a patient with Graves' disease.
    Valenti TM; Macchia E; Pisa R; Bucalo ML; Russo V; Colletti I; Compagno V; Abbadi V; Donatelli M
    J Endocrinol Invest; 1999 Oct; 22(9):701-4. PubMed ID: 10595835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperthyroid Graves' disease after hemithyroidectomy for papillary carcinoma: report of three cases.
    Misaki T; Iwata M; Kasagi K; Iida Y; Akamizu T; Kosugi S; Konishi J
    Endocr J; 2000 Apr; 47(2):191-5. PubMed ID: 10943744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A patient with an autonomously functioning thyroid nodule with papillary adenocarcinoma associated with Graves' hyperthyroidism.
    Tsuboi M; Shigemasa C; Ueta Y; Yoshida A; Kobayashi K; Mori T; Mashiba H
    Clin Nucl Med; 1995 Nov; 20(11):985-8. PubMed ID: 8565381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hyperthyroidism and cancer of the thyroid].
    Daou R
    Chirurgie; 1998 Dec; 123(6):604-8. PubMed ID: 9922602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of thyroid-stimulating antibodies of Graves' disease in differentiated thyroid cancer.
    Filetti S; Belfiore A; Amir SM; Daniels GH; Ippolito O; Vigneri R; Ingbar SH
    N Engl J Med; 1988 Mar; 318(12):753-9. PubMed ID: 3347223
    [No Abstract]   [Full Text] [Related]  

  • 19. Serendipitous detection of thyroid carcinoma in a patient with Graves' disease.
    Ahmad M; Johns W; Gupta SM
    Clin Nucl Med; 1999 Jan; 24(1):76. PubMed ID: 9890508
    [No Abstract]   [Full Text] [Related]  

  • 20. Early occurrence of a thyroid carcinoma in a patient who developed Graves' disease after treatment for Hodgkin's disease.
    Belfiore A; Pellegriti G; Milone G; Vigneri G; Gangemi P; Fiumara A; Vigneri R
    J Endocrinol Invest; 1995 Dec; 18(11):869-71. PubMed ID: 8778160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.